The Medicare Rx drug benefit could slash independent pharmacies' gross margins by 8%, sending them over the edge of unprofitability, according to industry analyst Arthur Flynn.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.